China quietly exempts U.S. goods from 125% tariffs to shield critical sectors amid trade tensions

Pallavi Madhiraju- April 30, 2025 0

China privately exempts key U.S. goods from 125% tariffs to ease pressure on industries; no formal deal or public confirmation announced. Read More

IBM unleashes $150bn in the U.S. to build the future of computing

Pallavi Madhiraju- April 29, 2025 0

IBM announces $150 billion U.S. investment to expand AI and quantum manufacturing leadership. Find out how it impacts the tech and stock market landscape today! Read More

Biggest U.S. pork deal collapse since COVID as China hits back in tariff fight

Pallavi Madhiraju- April 26, 2025 0

China cancels 12,000 metric tons of U.S. pork amid escalating tariff fight; USDA confirms major blow to American agriculture. Trade tensions rise. Read More

Xi Jinping unveils new measures to stabilise China’s economy amid trade war escalations

Pallavi Madhiraju- April 26, 2025 0

China launches stimulus to counter economic slowdown; Politburo signals targeted U.S. tariff cuts as part of stabilisation drive. Read More

China bends on tariffs: What U.S. businesses need to know about the new exemptions

Pallavi Madhiraju- April 26, 2025 0

China exempts some U.S. goods from 125% tariffs; Beijing invites firms to list critical products amid trade war fallout. Read More

Big tech earthquake: Apple to dump China for Indian iPhone production

Pallavi Madhiraju- April 25, 2025 0

Discover how Apple’s shift to India for US iPhone production under Trump’s second term could reshape global supply chains and impact investors worldwide! Read More

Game-changer for knee pain? Sun Pharma’s MM-II injection delivers lasting relief, wins FDA fast track

Pallavi Madhiraju- April 24, 2025 0

Sun Pharma and Moebius report breakthrough in knee osteoarthritis treatment with MM-II. Learn how this new therapy could reshape pain management. Read More

Trump teases major tariff rollback on China—Could this end the trade war?

Pallavi Madhiraju- April 24, 2025 0

Find out how Donald Trump’s comments on tariff reductions could reshape U.S.-China trade ties and impact global markets moving forward. Read More

ACIP expands Pfizer’s ABRYSVO vaccine guidance to include at-risk adults aged 50–59

Pallavi Madhiraju- April 21, 2025 0

Pfizer's RSV vaccine ABRYSVO now recommended for at-risk adults aged 50–59. Learn what it means for public health and Pfizer’s expanding vaccine portfolio. Read More

Trump’s ultimatum spurs U.S.-Iran nuclear deal breakthrough talks in Oman

Pallavi Madhiraju- April 20, 2025 0

Iran and the U.S. begin drafting a nuclear deal framework after making progress in indirect talks, raising hopes of de-escalation. Read the full update now. Read More

1234...1520 / 148 Posts